Cite

HARVARD Citation

    Harper, S. et al. (2023). Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease. Journal of medical economics. pp. 603-613. [Online]. 
  
Back to record